[News Article]2019 China BioMed Innovation and Investment Conference

21 Sep 2019
Title
2019 China BioMed Innovation and Investment Conference
Category
News Article


PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and CEO of PharmAbcine and Dr. Hyunsun Park, CBO/COO are attending to "2019 China BioMed Innovation and Investment Conference" in Suzhou, China on September 21-23 to have 1:1 partnering meetings. Dr. Jin-San Yoo will present PharmAbcine R&D progress at "International Innovative Oncology Companies Roadshow" on September 22, 2019.




http://2018cbiic.phirda.com/ 

https://www.cbiic.nfcr.org



Please check the attached file for details.




     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea


     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 


     COPYRIGHT BY PharmAbcine Inc.

     ALL RIGHTS RESERVE